The Binding Site for TRAF2 and TRAF3 but Not for TRAF6 Is Essential for CD40-Mediated Immunoglobulin Class Switching

Immunity

Volumn 17, Issue 3, 2002, Pages 265-276

  Jabara, Haifa H ^a   Laouini, Dhafer ^a   Tsitsikov, Erdyni ^a   Mizoguchi, Emiko ^b   Bhan, Atul K ^b   Castigli, Emanuela ^a   Dedeoglu, Fatma ^a   Pivniouk, Vadim ^a   Brodeur, Scott R ^a   Geha, Raif S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOPROTEIN; MUTANT PROTEIN; PROTEIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; GENE SWITCHING; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; TRANSGENE; WILD TYPE;

EID: 18644383624     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00394-1     Document Type: Article

References (51)

1. Aicher A., Shu G.L., Magaletti D., Mulvania T., Pezzutto A., Craxton A., Clark E.A. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 163:1999;5786-5795.
2. Bacharier L.B., Jabara H., Geha R.S. Molecular mechanisms of immunoglobulin E regulation. Int. Arch. Allergy Immunol. 115:1998;257-269.
3. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922.
4. Berberich I., Shu G.L., Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:1994;4357-4366.
5. Castigli E., Alt F., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., Geha R.S. CD40 deficient mice generated by RAG-2 deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91:1994;12135-12139.
6. Castigli E., Young F., Carossino A.M., Alt F.W., Geha R.S. CD40 expression and function in murine B cell ontogeny. Int. Immunol. 8:1996;405-411.
7. Cheng G., Cleary A.M., Ye Z., Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1498.
8. Chu C.C., Paul W.E., Max E.E. Quantitation of immunoglobulin μ-γ1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 89:1992;6978-6982.
9. Dadgostar H., Zarnegar B., Hoffmann A., Qin X.F., Truong U., Rao G., Baltimore D., Cheng G. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc. Natl. Acad. Sci. USA. 99:2002;1497-1502.
10. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., Bodemer C., Kenwrick S., Dupuis-Girod S., Blanche S.et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27:2001;277-285.
11. Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen F.S., Chatila T., Fu S.M., Stamenkovic I., Geha R.S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:1993;2170-2173.
12. Grammer A.C., Swantek J.L., McFarland R.D., Miura Y., Geppert T., Lipsky P.E. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 161:1998;1183-1193.
13. Hanissian S., Geha R.S. Jak3 is associated with Cd40 and is critical for CD40 induction of gene expression in b cells. Immunity. 6:1997;379-388.
14. Hasbold J., Lyons A.B., Kehry M.R., Hodgkin P.D. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 28:1998;1040-1051.
15. Iciek L.A., Delphin S.A., Stavnezer J. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB. synergy with IL-4 induction J. Immunol. 158:1997;4769-4779.
16. Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Mosialos G., Kieff E.et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:1996;28745-28748.
17. Jabara H.H., Fu S.M., Geha R.S., Vercelli D. CD40 and IgE. synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells J. Exp. Med. 172:1990;1861-1864.
18. Jabara H.H., Buckley R.H., Roberts J.L., Lefranc G., Loiselet J., Khalil G., Geha R.S. Role of JAK3 in CD40-mediated signaling. Blood. 92:1998;2435-2440.
19. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2:2001;223-228.
20. Jalukar S.V., Hostager B.S., Bishop G.A. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 164:2000;623-630.
21. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice. impaired immunoglobulin class switching and germinal center formation Immunity. 1:1994;167-178.
22. Lee H.H., Dempsey P.W., Parks T.P., Zhu X., Baltimore D., Cheng G. Specificities of CD40 signaling. involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation Proc. Natl. Acad. Sci. USA. 96:1999;1421-1426.
23. Leo E., Welsh K., Matsuzawa S., Zapata J.M., Kitada S., Mitchell R.S., Ely K.R., Reed J.C. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. J. Biol. Chem. 274:1999;22414-22422. a.
24. Leo E., Zapata J.M., Reed J.C. CD40-mediated activation of Ig-Cgamma1- and Ig-cepsilon germ-line promoters involves multiple TRAF family proteins. Eur. J. Immunol. 29:1999;3908-3913. b.
25. Li Y.Y., Baccam M., Waters S.B., Pessin J.E., Bishop G.A., Koretzky G.A. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157:1996;1440-1447.
26. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S.et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
27. Manis J.P., Tian M., Alt F.W. Mechanism and control of class-switch recombination. Trends Immunol. 23:2002;31-39.
28. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:2000;553-563.
29. Nagumo H., Agematsu K., Shinozaki K., Hokibara S., Ito S., Takamoto M., Nikaido T., Yasui K., Uehara Y., Yachie A., Komiyama A. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J. Immunol. 161:1998;6496-6502.
30. Naito A., Azuma S., Tanaka S., Miyazaki T., Takaki S., Takatsu K., Nakao K., Nakamura K., Katsuki M., Yamamoto T., Inoue J. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:1999;353-362.
31. Nakano H., Sakon S., Koseki H., Takemori T., Tada K., Matsumoto M., Munechika E., Sakai T., Shirasawa T., Akiba H.et al. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. USA. 96:1999;9803-9808.
32. Nguyen L.T., Duncan G.S., Mirtsos C., Ng M., Speiser D.E., Shahinian A., Marino M.W., Mak T.W., Ohashi P.S., Yeh W.C. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity. 11:1999;379-389.
33. Pullen S.S., Miller H.G., Everdeen D.S., Dang T.T., Crute J.J., Kehry M.R. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions. regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization Biochemistry. 37:1998;11836-11845.
34. Pype S., Declercq W., Ibrahimi A., Michiels C., Van Rietschoten J.G., Dewulf N., de Boer M., Vandenabeele P., Huylebroeck D., Remacle J.E. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J. Biol. Chem. 275:2000;18586-18593.
35. Reinhard C., Shamoon B., Shyamala V., Williams L.T. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1997;1080-1092.
36. Revy P., Hivroz C., Andreu G., Graber P., Martinache C., Fischer A., Durandy A. Activation of the Janus kinase 3-STAT5a pathway after CD40 triggering of human monocytes but not of resting B cells. J. Immunol. 163:1999;787-793.
37. Richards M.L., Katz D.H. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23). comparison with the germline epsilon promoter J. Immunol. 158:1997;263-272.
38. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
39. Sha W.C. Regulation of immune responses by NF-kappa B/Rel transcription factor. J. Exp. Med. 187:1998;143-146.
40. Shaw A.C., Swat W., Ferrini R., Davidson L., Alt F.W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189:1999;123-130.
41. Song H., Regnier C., Kirschning C., Goeddel D., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades. bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
42. Spergel J., Mizoguchi E., Brewer J., Martin T., Bhan A., Geha R. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to metacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101:1998;1614-1622.
43. Sutherland C.L., Krebs D.L., Gold M.R. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest. J. Immunol. 162:1999;4720-4730.
44. Tsitsikov E.N., Laouini D., Dunn I.F., Sannikova T.Y., Davidson L., Alt F.W., Geha R.S. Traf1 is a negative regulator of tnf signaling. enhanced tnf signaling in traf1-deficient mice Immunity. 15:2001;647-657.
45. Tsukamoto N., Kobayashi N., Azuma S., Yamamoto T., Inoue J. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA. 96:1999;1234-1239.
46. Werneburg B.G., Zoog S.J., Dang T.T., Kehry M.R., Crute J.J. Molecular characterization of CD40 signaling intermediates. J. Biol. Chem. 276:2001;43334-43342.
47. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J.J., Waldschmidt T.J., Elsemore J., Noelle R.J., Flavell R.A. Mice deficient for the CD40 ligand. Immunity. 1:1994;423-431.
48. Xu L., Rothman P. IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. Int. Immunol. 6:1994;515-521.
49. Xu Y., Cheng G., Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 5:1996;407-415.
50. Yamamoto H., Kishimoto T., Minomoto S. NF-κB activation in CD27 signaling. involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27 J. Immunol. 161:1998;4753-4759.
51. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N.et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.